Abstract
Systems biology is the comprehensive and quantitative analysis of the interactions between all of the components of biological systems over time. Cells of the innate immune system are the first line of defense against invading pathogens and orchestrate the ensuing adaptive response, which is critical to the establishment of long-term protective immunity. Innate immunity is well suited for systems analysis, because the relevant cells can be isolated in various functional states and many of their interactions can be reconstituted in a biologically meaningful manner. Application of the tools of systems biology to the innate immune system will enable comprehensive analysis of the complex interactions that maintain the fine balance between host defense and inflammatory disease. In this review, we discuss innate immunity in the context of the systems biology concepts, emergence, robustness, and modularity. We also describe recent efforts to apply these approaches to enable rational vaccine design and accelerate the pace of clinical vaccine trials.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Rappuoli R, Aderem A (2011) A 2020 vision for vaccines against HIV, tuberculosis and malaria. Nature 473(7348):463–469
Alon U (2007) Network motifs: theory and experimental approaches. Nat Rev Genet 8(6):450–461
Zak DE et al (2011) Systems analysis identifies an essential role for SHANK-associated RH domain-interacting protein (SHARPIN) in macrophage Toll-like receptor 2 (TLR2) responses. In: Proceedings of the National Academy of Sciences of the United States of America, 2011
Underhill DM, Ozinsky A (2002) Phagocytosis of microbes: complexity in action. Annu Rev Immunol 20:825–852
Aderem AA, Scott WA, Cohn ZA (1984) A selective defect in arachidonic acid release from macrophage membranes in high potassium media. J Cell Biol 99(4 Pt 1):1235–1241
Aderem AA (1985) Ligated complement receptors do not activate the arachidonic acid cascade in resident peritoneal macrophages. J Exp Med 161(3):617–622
Aderem AA (1986) Bacterial lipopolysaccharides prime macrophages for enhanced release of arachidonic acid metabolites. J Exp Med 164(1):165–179
Goodridge HS, Underhill DM (2008) Fungal Recognition by TLR2 and Dectin-1. Handb Exp Pharmacol 183:87–109
Blander JM, Medzhitov R (2004) Regulation of phagosome maturation by signals from toll-like receptors. Science 304(5673):1014–1018
Blander JM, Medzhitov R (2006) Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature 440(7085):808–812
Trinchieri G, Sher A (2007) Cooperation of Toll-like receptor signals in innate immune defence. Nat Rev Immunol 7(3):179–190
Miao EA et al (2006) Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1beta via Ipaf. Nat Immunol 7(6):569–575
Geddes BJ et al (2001) Human CARD12 is a novel CED4/Apaf-1 family member that induces apoptosis. Biochem Biophys Res Commun 284(1):77–82
Poyet JL et al (2001) Identification of Ipaf, a human caspase-1-activating protein related to Apaf-1. J Biol Chem 276(30):28309–28313
Masumoto J et al (2003) ASC is an activating adaptor for NF-kappa B and caspase-8-dependent apoptosis. Biochem Biophys Res Commun 303(1):69–73
Dinarello CA (1998) Interleukin-1 beta, interleukin-18, and the interleukin-1 beta converting enzyme. Ann N Y Acad Sci 856:1–11
Miao EA (2007) TLR5 and Ipaf: dual sensors of bacterial flagellin in the innate immune system. Semin Immunopathol 29(3):275–288
Stetson DB, Medzhitov R (2006) Type I interferons in host defense. Immunity 25(3):373–381
Kumar H et al (2008) Cutting edge: cooperation of IPS-1- and TRIF-dependent pathways in poly IC-enhanced antibody production and cytotoxic T cell responses. J Immunol 180(2):683–687
Edelmann KH (2004) Does Toll-like receptor 3 play a biological role in virus infections? Virology 322(2):231–238
Warren SE (2008) Multiple Nod-like receptors activate caspase 1 during Listeria monocytogenes infection. J Immunol 180(11):7558–7564
Roach JC (2005) The evolution of vertebrate Toll-like receptors. Proc Nat Acad Sci USA 102(27):9577–9582
Jin MS, Lee JO (2008) Structures of TLR-ligand complexes. Curr Opin Immunol 20(4):414–419
Jin MS (2007) Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell 130(6):1071–1082
Liu L (2008) Structural basis of toll-like receptor 3 signaling with double-stranded RNA. Science 320(5874):379–381
Honda K, Takaoka A, Taniguchi T (2006) Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors. Immunity 25(3):349–360
Liew FY (2005) Negative regulation of toll-like receptor-mediated immune responses. Nat Rev Immunol 5(6):446–458
Boone DL (2004) The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat Immunol 5(10):1052–1060
Wang YY (2004) A20 is a potent inhibitor of TLR3- and Sendai virus-induced activation of NF-kappaB and ISRE and IFN-beta promoter. FEBS Lett 576(1–2):86–90
Saitoh T (2005) A20 is a negative regulator of IFN regulatory factor 3 signaling. J Immunol 174(3):1507–1512
Lin R (2006) Negative regulation of the retinoic acid-inducible gene I-induced antiviral state by the ubiquitin-editing protein A20. J Biol Chem 281(4):2095–2103
Hitotsumatsu O (2008) The ubiquitin-editing enzyme A20 restricts nucleotide-binding oligomerization domain containing 2-triggered signals. Immunity 28(3):381–390
Bolouri H, Davidson EH (2003) Transcriptional regulatory cascades in development: initial rates, not steady state, determine network kinetics. Proc Nat Acad Sci USA 100(16):9371–9376
Smith J, Theodoris C, Davidson EH (2007) A gene regulatory network subcircuit drives a dynamic pattern of gene expression. Science 318(5851):794–797
Seymour RE (2007) Spontaneous mutations in the mouse Sharpin gene result in multiorgan inflammation, immune system dysregulation and dermatitis. Genes Immun 8(5):416–421
Zenewicz LA, Shen H (2007) Innate and adaptive immune responses to Listeria monocytogenes: a short overview. Microbes Infection/Institut Pasteur 9(10):1208–1215
Warren SE (2010) Cutting edge: Cytosolic bacterial DNA activates the inflammasome via Aim2. J Immunol 185(2):818–821
Leber JH (2008) Distinct TLR- and NLR-mediated transcriptional responses to an intracellular pathogen. PLoS Pathog 4(1):e6
Vadigepalli R (2003) PAINT: a promoter analysis and interaction network generation tool for gene regulatory network identification. OMICS 7(3):235–252
Subramanian A (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Nat Acad Sci USA 102(43):15545–15550
Siggs OM (2010) A mutation of Ikbkg causes immune deficiency without impairing degradation of IkappaB alpha. Proc Nat Acad Sci USA 107(7):3046–3051
Lim S (2001) Sharpin, a novel postsynaptic density protein that directly interacts with the shank family of proteins. Mol Cell Neurosci 17(2):385–397
Tokunaga F (2009) Involvement of linear polyubiquitylation of NEMO in NF-kappaB activation. Nat Cell Biol 11(2):123–132
Gerlach B (2011) Linear ubiquitination prevents inflammation and regulates immune signalling. Nature 471(7340):591–596
Ikeda F (2011) SHARPIN forms a linear ubiquitin ligase complex regulating NF-kappaB activity and apoptosis. Nature 471(7340):637–641
Tokunaga F (2011) SHARPIN is a component of the NF-kappaB-activating linear ubiquitin chain assembly complex. Nature 471(7340):633–636
Amit I (2009) Unbiased reconstruction of a mammalian transcriptional network mediating pathogen responses. Science 326(5950):257–263
Zak DE (2011) Systems analysis identifies an essential role for SHANK-associated RH domain-interacting protein (SHARPIN) in macrophage Toll-like receptor 2 (TLR2) responses. Proc Natl Acad Sci U S A 108(28):11536–11541
Litvak V (2009) Function of C/EBPdelta in a regulatory circuit that discriminates between transient and persistent TLR4-induced signals. Nat Immunol 10(4):437–443
Ramsey SA (2008) Uncovering a macrophage transcriptional program by integrating evidence from motif scanning and expression dynamics. PLoS Comput Biol 4(3):e1000021
Gilchrist M (2006) Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4. Nature 441(7090):173–178
Suzuki H (2009) The transcriptional network that controls growth arrest and differentiation in a human myeloid leukemia cell line. Nat Genet 41(5):553–562
Querec TD (2009) Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nat Immunol 10(1):116–125
Gaucher D (2008) Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses. J Exp Med 205(13):3119–3131
Nakaya HI (2011) Systems biology of vaccination for seasonal influenza in humans. Nat Immunol 12(8):786–795
Pulendran B, Li S, Nakaya HI (2010) Systems vaccinology. Immunity 33(4):516–529
Zak DE, Aderem A (2009) Systems biology of innate immunity. Immunol Rev 227(1):264–282
Shapira SD, Hacohen N (2011) Systems biology approaches to dissect mammalian innate immunity. Curr Opin Immunol 23(1):71–77
Gardy JL (2009) Enabling a systems biology approach to immunology: focus on innate immunity. Trends Immunol 30(6):249–262
Bosinger SE (2009) Global genomic analysis reveals rapid control of a robust innate response in SIV-infected sooty mangabeys. J Clin Invest 119(12):3556–3572
Palermo RE (2011) Genomic analysis reveals pre- and postchallenge differences in a rhesus macaque AIDS vaccine trial: insights into mechanisms of vaccine efficacy. J Virol 85(2):1099–1116
Hersperger AR (2011) Qualitative features of the HIV-specific CD8 + T-cell response associated with immunologic control. Curr Opin HIV AIDS 6(3):169–173
Querec T (2006) Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity. J Exp Med 203(2):413–424
Lindsay RW (2010) CD8 + T cell responses following replication-defective adenovirus serotype 5 immunization are dependent on CD11c + dendritic cells but show redundancy in their requirement of TLR and nucleotide-binding oligomerization domain-like receptor signaling. J Immunol 185(3):1513–1521
Delaloye J (2009) Innate immune sensing of modified vaccinia virus Ankara (MVA) is mediated by TLR2-TLR6, MDA-5 and the NALP3 inflammasome. PLoS Pathog 5(6):e1000480
Brooks JPL (2008) E.K., Analysis of the consistency of a mixed integer programming-based multi-category constrained discriminant model. Ann Oper Res 1–64:1–20
Zou HH, Hastie T (2005) Regularization and variable selection via the elastic net. J R Stat Soc B. 67(Part 2):301–320
Araki K (2009) mTOR regulates memory CD8 T-cell differentiation. Nature 460(7251):108–112
Tan X (2011) Retinoic acid as a vaccine adjuvant enhances CD8 + T cell response and mucosal protection from viral challenge. J Virol 85(16):8316–8327
Freidlin B, Simon R (2005) Adaptive signature design: an adaptive clinical trial design for generating and prospectively testing a gene expression signature for sensitive patients. Clin Cancer Res: An Off J Am Assoc Cancer Res 11(21):7872–7878
Campbell H (2009) Meningococcal C conjugate vaccine: the experience in England and Wales. Vaccine 27(Suppl 2):B20–B29
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Diercks, A., Aderem, A. (2012). Systems Approaches to Dissecting Immunity. In: Katze, M. (eds) Systems Biology. Current Topics in Microbiology and Immunology, vol 363. Springer, Berlin, Heidelberg. https://doi.org/10.1007/82_2012_246
Download citation
DOI: https://doi.org/10.1007/82_2012_246
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-33098-8
Online ISBN: 978-3-642-33099-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)